Wyeth Materna Case Closes As Firm Runs Out Of Options
This article was originally published in The Tan Sheet
Executive Summary
The U.S. Supreme Court will not hear Wyeth's appeal of a $58.3 mil. judgment for patent fraud and unjust enrichment, ending an 11-year court battle in the Materna prenatal vitamin line case